Malignant pleural effusions (MPE) are a common pathology, treated by respiratory
physicians and thoracic surgeons alike. In recent years, several well-designed randomized …

Thoracic ultrasound is increasingly considered to be an essential tool for the pulmonologist.
It is used in diverse clinical scenarios, including as an adjunct to clinical decision making for …

There are substantial differences in international guidelines for the management of
pneumothorax and much geographical variation in clinical practice. These discrepancies …

Background The impact of COVID-19 on physical and mental health and employment after
hospitalisation with acute disease is not well understood. The aim of this study was to …

Background The medium-term effects of Coronavirus disease (COVID-19) on organ health,
exercise capacity, cognition, quality of life and mental health are poorly understood …

Background The safety, effectiveness, and cost-effectiveness of molnupiravir, an oral
antiviral medication for SARS-CoV-2, has not been established in vaccinated patients in the …

Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection
carries a substantial risk of severe and prolonged illness; treatment options are currently …

Background More than 30% of patients with pleural infection either die or require surgery.
Drainage of infected fluid is key to successful treatment, but intrapleural fibrinolytic therapy …

Context Malignant pleural effusion causes disabling dyspnea in patients with a short life
expectancy. Palliation is achieved by fluid drainage, but the most effective first-line method …

Local anaesthetic thoracoscopy: British Thoracic Society pleural disease guideline 2010 |
Thorax Skip to main content Viewing from: Google Indexer BMJ Journals Subscribe Log In More …